.png)
How to Choose Ketamine Infusion vs Nasal Spray for Panic
Last Updated: November 2, 2026
Quick Summary
Neither a ketamine infusion nor esketamine nasal spray is FDA-approved for panic disorder, so the choice is off-label and belongs in a careful conversation with a physician. Panic-specific evidence is thin, and no head-to-head trial settles the comparison, so treat confident claims in either direction with caution.
IV ketamine offers precise, adjustable dosing with nearly immediate onset, while nasal esketamine is fixed per device and slower to peak.
Both routes are clinician-supervised, require blood pressure monitoring, and need a ride home afterward.
Ask for a written full-course estimate covering evaluation, induction sessions, and maintenance visits, not a single-session figure.
Cardiovascular history, substance-use history, and current medications all shape eligibility for either route.
First-line panic care remains CBT plus an SSRI or SNRI before ketamine is considered.
Table of Contents
Ketamine for Panic Disorder: What the Evidence Actually Shows
If you are weighing a ketamine infusion versus nasal spray for panic disorder, start with an honest fact: a ketamine infusion and esketamine nasal spray are both unapproved by the FDA for panic disorder.
Panic disorder is different from depression in ways that matter here. Depression often flattens mood and energy over weeks. Panic disorder runs on sudden surges: racing heart, shortness of breath, dizziness, and a fear of the next attack.
Why Panic Disorder Is Different from Depression
Depression tends to be steady and slow-moving. Clinicians must therefore rely on a nuanced understanding of the physiological markers distinguishing anxiety and panic to determine whether ketamine might effectively interrupt these acute, unpredictable episodes.
The diagnostic distinction matters for treatment selection. Panic disorder is defined by recurrent, unexpected panic attacks plus persistent worry about future attacks or behavior change to avoid them (Panic Disorder: What You Need to Know).
What the Panic-Specific Evidence Actually Looks Like
It helps to separate three tiers of evidence, because they carry very different weight:
Randomized controlled trials. Panic-disorder-specific randomized trials of ketamine are few and small.
Open-label and observational reports. A larger body of case series and open-label studies describes reductions in panic and anxiety symptoms after IV ketamine, often in patients whose primary diagnosis was depression. These are hypothesis-generating, not confirmatory.
Clinical experience. Clinicians who use ketamine off-label for anxiety report that some patients experience a meaningful drop in panic frequency and anticipatory fear, while others see little change or a temporary increase in anxiety during the session itself.
A key limitation is outcome measurement. Depression trials use rating scales such as the MADRS or PHQ-9. Panic research relies on measures like panic attack frequency, the Panic Disorder Severity Scale, and agoraphobic avoidance, endpoints that are not routinely collected in ketamine depression studies. That mismatch is why a strong depression response cannot be read as proof of panic efficacy.
What We Know and What Remains Uncertain
What we know: ketamine affects glutamate signaling, particularly at the NMDA receptor, and appears to support rapid changes in neural connectivity, which is why mood can shift within hours rather than weeks. What remains uncertain: whether those shifts translate into fewer panic attacks, whether the effect holds beyond the days and weeks after a course, and whether nasal esketamine produces comparable panic-specific effects at all.
Key Takeaway Depression response data do not establish that either ketamine route works for panic disorder, and no head-to-head panic-disorder trial currently settles the comparison. Treat any confident claim to the contrary, in either direction, as a signal to ask harder questions.
Where Established Care Fits
Before pursuing ketamine, it is reasonable to ask whether you have had an adequate trial of first-line panic disorder treatment: a structured course of CBT, an SSRI or SNRI at a therapeutic dose for an adequate duration, and a plan for managing avoidance. Ketamine may be considered when those approaches have not worked, when symptoms are severe, or when a rapid bridge is needed, always with a clear plan for what happens after the acute phase.
Ketamine vs Esketamine: Two Drugs, Two Delivery Routes
Ketamine is the older drug. It is a racemic mixture containing two mirror-image molecular forms. Esketamine is just one of those forms, isolated and packaged as a nasal spray. Same family, different chemistry and different delivery.
The practical differences come down to control and convenience:
IV ketamine goes directly into the bloodstream, so a clinician controls the dose precisely and can adjust mid-session.
Nasal esketamine is absorbed through the nasal lining and requires supervision in a certified setting.
Onset with an IV infusion is nearly immediate; nasal absorption takes a bit longer to peak.
For a deeper look at the nasal spray option specifically, our Spravato® (esketamine) page explains how that treatment is structured.
How Each Treatment Is Administered and Supervised
Both routes are clinician-supervised, and neither is a take-home treatment. Supervision is not bureaucracy; it is the safety mechanism.
The IV Infusion Experience
You recline in a chair while a clinician places a small IV line, usually in the arm or hand. The infusion runs over a set period while your blood pressure, heart rate, and comfort are checked. Many people describe the experience as dreamlike or detached. A staff member stays nearby throughout, and you rest afterward until you are steady. You will need a ride home.
The Nasal Spray Experience
The nasal spray is given in a supervised clinical setting, one dose per device, with a period of observation afterward. Blood pressure monitoring matters here too. Because absorption varies from person to person, the observation window is part of the treatment, not an afterthought.
Ketamine Therapy Side Effects and Safety Monitoring
The most common ketamine therapy side effects are short-lived and manageable in a supervised setting. Less common but more serious concerns, such as urinary symptoms with heavy long-term use, are why dosing discipline matters. (Source: a review of ketamine's efficacy in various psychiatric conditions)
Safety monitoring is where clinics differ most. Blood pressure checks, mental status observation, and a clear plan for follow-up are baseline expectations. A common mistake is treating these as optional extras. They are the treatment.
How Long Does Ketamine Treatment Last?
How long does ketamine treatment last depends on the route and the person. An individual IV infusion typically runs under an hour, with recovery time added. A nasal spray session includes dosing plus an observation period afterward.
The bigger question is durability of benefit. Relief from a single session is often temporary, and clinicians commonly use an induction phase of several sessions followed by maintenance treatment spaced further apart.
Question | IV Ketamine | Nasal Esketamine |
FDA status for panic disorder | Off-label | Off-label |
Session length | Infusion plus recovery | Dosing plus observation |
Onset of effect | Very fast | Fast, slightly slower to peak |
Dose control | Precise, adjustable mid-session | Fixed per device |
Monitoring | Blood pressure, heart rate, observation | Blood pressure, observation |
Ride home required | Yes | Yes |
Practical Considerations: Access, Cost, and Eligibility
Coverage is uneven, and the sticker price of a single session is a poor guide to what treatment actually costs over a course. Coverage is uneven, and insurance decisions depend on your specific plan and diagnosis. We do not publish prices here because cost depends on your plan, your session count, and your care plan. Ask for a written estimate before you start, and ask what happens if the first few sessions do not help.
The Full Cost Picture, Not Just the Session Fee
A per-session number can hide much of the real expense. When you compare routes, ask about each of these line items:
Initial psychiatric evaluation. A diagnostic assessment is usually required before either route and is often billed separately.
The treatment session itself. IV ketamine is typically billed per infusion; nasal esketamine is billed per dose plus the observation period.
Induction course. Clinicians commonly use several sessions in the first few weeks. Multiply the per-session figure by the planned induction count before comparing.
Maintenance visits. Ongoing spaced sessions are common, and their frequency is the single largest driver of annual cost.
Ancillary care. Therapy, psychiatric follow-up, and medication management are often part of a complete plan and are billed on their own.
Watch Out A quoted per-session price that excludes evaluation, monitoring, induction count, and maintenance frequency can understate the true cost of a course by a wide margin. Ask for the full-course estimate in writing, not the single-session figure.
Insurance and Reimbursement Reality
Coverage criteria vary by plan, and your insurer can explain what documentation it requires. If you are weighing the infusion route, our article on IV ketamine cost and insurance walks through what to expect. For the nasal spray route, Spravato coverage and costs covers the insurance and cost questions in more detail.
Eligibility and Contraindications Relevant to Panic Disorder
Eligibility usually requires a confirmed diagnosis, prior trials of standard treatments, and a review of cardiovascular history and current medications. For panic disorder specifically, several factors deserve extra attention:
Cardiovascular history. Both routes can raise blood pressure transiently. Uncontrolled hypertension, certain cardiac conditions, and a history of aneurysmal disease are reasons for careful review or exclusion.
Substance-use history. Ketamine has misuse potential, and a history of substance use disorder changes the risk-benefit calculation and the monitoring plan.
Dissociation and transient anxiety. The acute ketamine experience can include dissociation and, in some patients, a temporary increase in anxiety. For someone with panic disorder, those sensations can resemble a panic attack, which is why set, setting, and clinician support matter.
Questions to Ask Before You Choose a Route
Bring a symptom log, a list of every medication and supplement you take, and a short list of questions. Ask directly: Is there panic-specific evidence relevant to my presentation? What does the full course cost, including evaluation, monitoring, induction, and maintenance? What monitoring happens during and after each session? How will we measure whether it is working, and when will we stop if it is not?
Discussing Ketamine Options with a Physician
Bring three things to the conversation: a symptom log, a list of every medication and supplement you take, and your questions. Ask directly whether the evidence supports ketamine for your specific presentation, what monitoring will look like, and how success will be measured. If a clinic cannot answer those plainly, keep looking.
At North Idaho Ketamine & TMS, our care is physician-led, and we combine IV ketamine therapy with TMS protocols and integrative wellness counseling rather than treating any single session as a cure. If you are still deciding between routes, our treatment quiz can help you see which options may fit. For panic-specific context, read more on ketamine therapy for panic disorder.
The old teachers understood uncertainty better than most. Rumi wrote that the wound is where the light enters. We take that seriously: healing rarely arrives in a straight line, and asking hard questions about your care is not doubt, it is wisdom.
If you are tired of surviving each day and want to move toward something steadier, we would be glad to talk. Our team offers physician-led IV ketamine therapy, one-day and accelerated TMS protocols, and integrative wellness counseling built around your situation.
Frequently Asked Questions
Is ketamine approved to treat panic disorder?
No. The FDA has not approved ketamine infusion or esketamine nasal spray specifically for panic disorder. Esketamine is FDA-approved for treatment-resistant depression, and IV ketamine is used off-label for several conditions. Any use for panic symptoms would be an off-label decision made by a qualified clinician after a full assessment. Ask your physician about the evidence base for your specific diagnosis before starting treatment.
What is the difference between ketamine and esketamine nasal spray?
Ketamine is a mixture containing both enantiomers, while esketamine is only the S-enantiomer and is delivered as a nasal spray. The ketamine vs esketamine distinction matters for administration: IV ketamine is given as an infusion in a clinic, and esketamine is sprayed into the nose under supervision. Both require monitoring, but the delivery route, dosing schedule, and FDA status differ.
How long does ketamine treatment last for panic symptoms?
Relief from a single ketamine infusion may last days to a few weeks, and esketamine follows a similar pattern with maintenance dosing. There is no fixed answer to how long does ketamine treatment last because response varies by person, diagnosis, and treatment schedule. Many clinics use an induction phase followed by maintenance sessions. Your clinician can adjust the plan based on how you respond.
What are the common ketamine therapy side effects?
Ketamine therapy side effects can include dissociation, dizziness, nausea, vomiting, and temporary blood pressure changes. These usually occur during or shortly after the session and are managed with supervision. Because blood pressure and sedation are monitored, treatment should only happen in a clinical setting. Tell your clinician about any heart conditions, blood pressure issues, or medications before treatment.
Comments